Suzhou Highfine Biotech Co., Ltd. (SHE:301393)

Suzhou Highfine Biotech Revenue

In the year 2025, Suzhou Highfine Biotech had annual revenue of 602.26M CNY with 33.28% growth. Suzhou Highfine Biotech had revenue of 167.56M in the quarter ending December 31, 2025, with 35.44% growth.

• Revenue: 602.26M
• Revenue Growth: +33.28%
• P/S Ratio: 10.41
• Revenue / Employee: 1.41M
• Employees: 428
• Market Cap: 6.27B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	602.26M	150.39M	33.28%
Dec 31, 2024	451.87M	63.08M	16.22%
Dec 31, 2023	388.79M	-58.66M	-13.11%
Jan 1, 2023	447.46M	78.02M	21.12%
Dec 31, 2021	369.44M	87.09M	30.85%